The oral vaccine intrOv is attenuated in infecting the lower airway and inducing chronic pathology
. Thus, we have demonstrated the airway safety of intrOv as an oral vaccine and provided evidence supporting its development as an airway vaccine to induce systemic immunity.
Authors
- Zhaoyang Liu (ORCID: https://orcid.org/0000-0002-3841-1804)
- Shuping Hou (ORCID: https://orcid.org/0000-0002-0913-5847)
- Guangming Zhong (ORCID: https://orcid.org/0000-0001-7053-5009)
- Sydney Mahan
- Jie Ren
- Caiting Li
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Infection and Immunity
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1128/iai.00122-26
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00